Outcomes following HDR Brachytherapy Boost for High Risk Localised Prostate Cancer: Data from a UK Centre

被引：0
|
作者：
Lorimer, C. [1 ]
Ravi, B. [1 ]
Cowtan, F. [1 ]
Johns, A. [1 ]
Robinson, A. [1 ]
Nikapota, A. [1 ]
机构：
[1] Univ Hosp Sussex NHS Trust, Brighton, England
来源：
CLINICAL ONCOLOGY | 2023年 / 35卷 / 02期
关键词：
DOSE-RATE BRACHYTHERAPY; INTERMEDIATE; MONOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E241 / E241
页数：1
相关论文
共 50 条
  • [21] High dose rate (HDR) brachytherapy boost for prostate cancer gives high control rate
    Flynn, J. P.
    Kelly, D. A.
    Brookover, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S323 - S324
  • [22] HDR Prostate Brachytherapy Boost for T3b Cancer: The Stokes Centre for Urology Experience
    Metawe, M.
    Mehta, S.
    Uribe, S.
    Otter, S.
    Long, M.
    Langley, S.
    [J]. CLINICAL ONCOLOGY, 2022, 34 (03) : E146 - E146
  • [23] MRI-guided Ultrafocal HDR-brachytherapy for Localised Prostate Cancer
    David, John
    Kamrava, Mitchell
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1182 - 1183
  • [24] Salvage HDR brachytherapy for localised recurrent prostate cancer after primary irradiation
    Stankiewicz, M.
    Wojcieszek, P.
    Lelek, P.
    Krzysztofiak, T.
    Kellas-Sleczka, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1096 - S1097
  • [25] Population outcomes of EBRT with LDR brachytherapy boost for intermediate, high-risk prostate cancer
    Oh, J.
    Spadinger, I.
    Lapointe, V.
    Morris, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S372 - S372
  • [26] SINGLE FRACTION HDR BRACHYTHERAPY AS ANTICIPATED BOOST IN LOCALIZED PROSTATE CANCER
    Cerrotta, A.
    Fallai, C.
    Carrara, M.
    Borroni, M.
    Villa, S.
    Bedini, N.
    Garcia, M.
    Maucione, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S288 - S289
  • [27] HDR BRACHYTHERAPY OF PROSTATE CANCER AS A BOOST AFTER EXTERNAL BEAM RADIOTHERAPY
    Kanikowski, M.
    Skowronek, J.
    Kubaszewska, M.
    Chichel, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S324 - S324
  • [28] The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer
    Thiruthaneeswaran, N.
    Bibby, B. A. S.
    Pereira, R.
    More, E.
    Denley, H.
    Henry, A.
    Wylie, J.
    Hoskin, P.
    Bristow, R.
    Choudhury, A.
    West, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S1086 - S1087
  • [29] Pretherapeutic nomogram predicting disease recurrence following HDR- brachytherapy for high risk-prostate cancer
    Schwarz, R.
    Chun, F. K. H.
    Karakiewicz, P., I
    Gallina, A.
    Walz, J.
    Briganti, A.
    Steuber, T.
    Schlomm, T.
    Haese, A.
    Graefen, M.
    Suardi, N.
    Alberti, W.
    Huland, H.
    Kruell, A.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 139 - 139
  • [30] Outcomes of 11 Years of Prostate LDR Brachytherapy at a UK Centre
    Chadwick, E.
    Langley, S.
    Laing, R.
    [J]. CLINICAL ONCOLOGY, 2011, 23 (03) : S32 - S33
12345